Parexel International is Biotechnology in United States that focus on new treatments business. Founded in 1982. They cover business area such as Provider, biopharmaceutical service, scientific discovery, new treatment, expertise-base clinical research, consulting, medical communication, technology, solution, medical device, industry, drug development, commercialization continuum, clinical trial management, reimbursement.
1982
( 44 years old in 2026 )
New Treatments
-
275 Grove Street
Suite 101C
Newton, MA 02466
United States
Private
Providerbiopharmaceutical servicescientific discoverynew treatmentexpertise-base clinical researchconsultingmedical communicationtechnologysolutionmedical deviceindustrydrug developmentcommercialization continuumclinical trial managementreimbursement
* We use standard office opening hours in near Parexel International's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Parexel International is Biotechnology business from United States that founded in 1982 (44 years old in 2026), Parexel International business is focusing on New Treatments.
Parexel International headquarter office and corporate office address is located in 275 Grove Street Suite 101C Newton, MA 02466 United States.
Parexel International was founded in United States.
In 2026, Parexel International is currently focus on new treatments sector.
Above is snippet of Google Trends for "new treatments" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Parexel International, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
